Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-15-004623
Filing Date
2015-05-26
Accepted
2015-05-26 21:16:13
Documents
1
Period of Report
2015-05-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1501260_x2.html 4  
1 OWNERSHIP DOCUMENT t1501260_x2.xml 4 3986
  Complete submission text file 0001571049-15-004623.txt   5538
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address
Banham John Michael Middlecott (Reporting) CIK: 0001357635 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 15890792